Varian Medical Systems Management to Present at Lazard Capital Markets 7th Annual Healthcare Conference | Varian

{ "pageType": "news-article", "title": "Varian Medical Systems Management to Present at Lazard Capital Markets 7th Annual Healthcare Conference", "articleDate": "November 05, 2010", "introText": "", "category": "Corporate and Financial Releases" }

Varian Medical Systems Management to Present at Lazard Capital Markets 7th Annual Healthcare Conference

PALO ALTO, Calif., Nov. 5, 2010 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) is scheduled to present at Lazard Capital Markets Healthcare Conference at 9:30 a.m. ET on Wednesday, November 17th at the St. Regis Hotel in New York City.

Participating executives will include Elisha Finney, senior vice president and CFO, and Spencer Sias, vice president of investor relations and corporate communications. The presentation will focus on the company's growth opportunities in radiation oncology, X-ray imaging, proton therapy and security and inspection.

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, China and Europe and in its 79 sales and support offices around the world. For more information, visit http://www.varian.com.

FOR INFORMATION CONTACT:

Spencer Sias, (650) 424-5782

Vice President, Corporate Communications

and Investor Relations

spencer.sias@varian.com



SOURCE Varian Medical Systems, Inc.